BioSignia Rolls Out National Marketing Campaign with 919 Marketing Company
Summary
In addition, the company’s cutting-edge underwriting technology enables life insurance companies to attract and retain higher value customers, as well as to bring new products to market more speedily and efficiently.“We are excited to have been selected to drive the marketing efforts of what promises to be the new gold standard for the early detection of chronic disease risks,” said David Chapman, CEO of 919.Headquartered just outside of North Carolina’s Research Triangle Park with a satellite office in downtown Washington D.C., 919 was founded over a decade ago by CEO David Chapman.919 is an unconventional firm with an uncanny ability to develop winning marketing strategies for a roster of companies including Biosignia, Cornerstone Biopharma, Coalition to Salute America’s Heroes, Jersey Mike’s, Kerr Drug, The Rosetta Stone, Social Technologies and Unilever Brands.With offices in Holly Springs N.C. and Washington D.C., 919 is a nationally recognized marketing consulting and public relations firm focused on the health and wellness market.Accurately assessing the likelihood that individuals will develop a chronic, preventable disease resulting in poor quality of life, declining productivity and higher healthcare costs has become a major concern of healthcare providers, insurers, and employers alike.